Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2019-04-10 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
独立董事关于第七届董事会第八次会议相关事项的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent directors' opinion report on various company matters including related party transactions, external guarantees, internal control self-assessment, profit distribution plan, auditor reappointment, use of raised funds, stock option plan cancellation, retrospective financial data adjustments, accounting policy changes, and use of idle raised funds. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and discusses compliance with laws and company articles. The document is detailed and substantive, providing independent opinions on financial and governance matters for the fiscal year 2018. It is not a full annual report but a specialized audit-related and governance-related opinion document. This fits best with the Audit Report / Information (AR) category, which includes standalone audit reports, applied accounting principles, and related regulatory compliance opinions. The document length is under 5,000 characters but contains detailed independent opinions rather than just an announcement or certification, so it is not RPA or RNS. Therefore, the classification is AR with high confidence. FY 2018
2019-04-10 Chinese
第七届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 8th meeting of the 7th Board of Directors of Huabang Life Health Co., Ltd. It includes voting results on various reports and proposals related to the 2018 fiscal year, such as the 2018 Board Work Report, General Manager Work Report, Financial Statements, Profit Distribution Plan, Annual Report and its summary, Internal Control Self-Evaluation Report, and other related matters. The document repeatedly states that these reports have been published elsewhere (e.g., on cninfo.com.cn and various newspapers) and that the resolutions will be submitted to the 2018 Annual General Meeting for approval. The document itself does not contain the full annual report or financial statements but rather the board's approval of these documents and related proposals. This type of document is a Board/Management Information announcement, specifically about board meeting resolutions and approvals, not the actual annual report or financial statements. Therefore, the correct classification is MANG (Board/Management Information). The document length (3530 characters) and content support this classification with high confidence.
2019-04-10 Chinese
西南证券股份有限公司关于公司使用暂时闲置的部分募集资金进行现金管理的核查意见
Regulatory Filings
2019-04-10 Chinese
西南证券股份有限公司关于公司2018年募集资金之发行股份购买资产并募集配套资金存放与使用情况的专项核查意见
Regulatory Filings
2019-04-10 Chinese
2018年度独立董事述职报告（武文生）
Board/Management Information Classification · 95% confidence The document is titled '2018年度独立董事述职报告' which translates to '2018 Independent Director's Work Report'. It details the independent director's attendance at board meetings, opinions on various company matters, on-site investigations, and efforts to protect investor rights during the 2018 fiscal year. The content focuses on the independent director's duties and opinions rather than presenting full financial statements or audit results. It is a report by an independent director about their work and oversight activities for the year, which is a type of management or governance report but does not fit the typical Annual Report (10-K), Audit Report (AR), or Management Discussion & Analysis (MDA). It is not a simple announcement or certification but a substantive report on director activities and opinions. This aligns best with a Board/Management Information (MANG) filing, which covers announcements related to board or senior management activities and reports. The document length is 4614 characters, which is substantive but not a full financial report. Therefore, the classification is MANG with high confidence.
2019-04-10 Chinese
2018年度独立董事述职报告（梁爽）
Board/Management Information Classification · 95% confidence The document is titled '2018年度独立董事述职报告' which translates to '2018 Independent Director's Work Report'. It is a detailed report by an independent director about their activities, attendance at board meetings, opinions on company matters, investigations, and efforts to protect shareholder interests during the year 2018. The content focuses on governance, oversight, and compliance with laws and regulations, rather than financial results or audit opinions. It is not an annual report, audit report, earnings release, or any other financial statement. It is a governance-related report detailing the independent director's duties and activities, which fits best under Board/Management Information (MANG) as it relates to management and board-level disclosures about director activities and governance. The document length is 3641 characters, which is a full report rather than a brief announcement. Therefore, the classification is MANG with high confidence.
2019-04-10 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.